141 related articles for article (PubMed ID: 27388998)
1. Are sertraline, paroxetine and duloxetine the most effective antidepressants for use in depressed adults over 60 years?
IsHak WW; Naghdechi L
Evid Based Ment Health; 2016 Nov; 19(4):e26. PubMed ID: 27388998
[No Abstract] [Full Text] [Related]
2. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
3. Is one selective serotonin reuptake inhibitor better than another?
Keeley R
JAMA; 2002 Apr; 287(15):1936-7; author reply 1937-8. PubMed ID: 11960528
[No Abstract] [Full Text] [Related]
4. Is one selective serotonin reuptake inhibitor better than another?
Culpepper L; Heeren T
JAMA; 2002 Apr; 287(15):1936; author reply 1937-8. PubMed ID: 11960527
[No Abstract] [Full Text] [Related]
5. Is one selective serotonin reuptake inhibitor better than another?
Stopa SF
JAMA; 2002 Apr; 287(15):1935-6; author reply 1937-8. PubMed ID: 11960526
[No Abstract] [Full Text] [Related]
6. Is one selective serotonin reuptake inhibitor better than another?
Elliott RL; Dane FC
JAMA; 2002 Apr; 287(15):1935; author reply 1937-8. PubMed ID: 11960525
[No Abstract] [Full Text] [Related]
7. Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication.
Tamblyn R; Bates DW; Buckeridge DL; Dixon WG; Girard N; Haas JS; Habib B; Iqbal U; Li J; Sheppard T
J Am Geriatr Soc; 2020 Jul; 68(7):1494-1503. PubMed ID: 32181493
[TBL] [Abstract][Full Text] [Related]
8. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome L
J Affect Disord; 2016 May; 196():225-33. PubMed ID: 26938965
[TBL] [Abstract][Full Text] [Related]
9. Advances in Pharmacotherapy of Late-Life Depression.
Beyer JL; Johnson KG
Curr Psychiatry Rep; 2018 Apr; 20(5):34. PubMed ID: 29627920
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of refractory hypochondriasis with duloxetine.
Politi P; Emanuele E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1145-6. PubMed ID: 17493731
[No Abstract] [Full Text] [Related]
11. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
Kroenke K; West SL; Swindle R; Gilsenan A; Eckert GJ; Dolor R; Stang P; Zhou XH; Hays R; Weinberger M
JAMA; 2001 Dec; 286(23):2947-55. PubMed ID: 11743835
[TBL] [Abstract][Full Text] [Related]
12. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
Mullins CD; Shaya FT; Meng F; Wang J; Harrison D
Pharmacotherapy; 2005 May; 25(5):660-7. PubMed ID: 15899727
[TBL] [Abstract][Full Text] [Related]
13. Antidepressants for anxiety disorders in late-life: A systematic review.
Balasubramaniam M; Joshi P; Alag P; Gupta S; Maher S; Tampi D; Gupta A; Young J; Tampi RR
Ann Clin Psychiatry; 2019 Nov; 31(4):277-291. PubMed ID: 31369663
[TBL] [Abstract][Full Text] [Related]
14. Psychopharmacological treatment of major depressive disorder in children and adolescents.
Varley CK
JAMA; 2003 Aug; 290(8):1091-3. PubMed ID: 12941683
[No Abstract] [Full Text] [Related]
15. Are paroxetine, fluoxetine, and sertraline equally effective for depression?
Straton JB; Cronholm P
J Fam Pract; 2002 Mar; 51(3):285. PubMed ID: 11978244
[No Abstract] [Full Text] [Related]
16. [Selective serotonin reuptake inhibitors--current knowledge].
Dudek D; Zieba A; Siwek M; Wróbel A
Psychiatr Pol; 2004; 38(3):507-24. PubMed ID: 15199659
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
[TBL] [Abstract][Full Text] [Related]
18. Impact of chosen cutoff on response rate differences between selective serotonin reuptake inhibitors and placebo.
Lisinski A; Hieronymus F; Nilsson S; Eriksson E
Transl Psychiatry; 2022 Apr; 12(1):160. PubMed ID: 35422023
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Kishi T; Ikuta T; Sakuma K; Okuya M; Hatano M; Matsuda Y; Iwata N
Mol Psychiatry; 2023 Jan; 28(1):402-409. PubMed ID: 36253442
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
Sun Y; Liang Y; Jiao Y; Lin J; Qu H; Xu J; Zhao C
BMJ Open; 2017 Aug; 7(8):e016499. PubMed ID: 28775189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
